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Gonadotropin-releasing hormone (GnRH) regulates the synthesis and secretion of follicle-stimulat-
ing hormone (FSH) by stimulating the transcription of Fshb gene. Our iTRAQ quantitative proteomics
result showed that the abundance of a-actinin4 (ACTN4) increased in the nuclei of LbT2 cells upon
GnRH induction. Using RNA interference, reverse transcription and real-time PCR, luciferase and
transient transfection assays, we proved that ACTN4 is involved in the regulation of mouse Fshb gene
(mFshb) transcription and its C-terminal calmodulin (CaM)-like domain is crucial for this process.
Our study suggests that ACTN4 nuclear translocation mediates GnRH stimulation of mFshb gene
transcription.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Gonadotropin-releasing hormone (GnRH), a hypothalamic
decapeptide, serves as a key hormone to regulate reproduction of
vertebrates. GnRH is released from hypothalamus and functions
through GnRH receptor (GnRHR) binding to induce the activation
of multiple downstream signaling pathways, which eventually
stimulate the synthesis and secretion of pituitary gonadotropins
luteinizing hormone (LH) and follicle-stimulating hormone (FSH)
[1]. LH and FSH are key regulators of reproductive development
and functions. Therefore, elucidating the mechanisms underlying
GnRH response to gonadotropins is of great importance to under-
stand the molecular basis of reproduction. The gonadotropins LH
and FSH are heterodimeric hormones, each of which contains an
identical a-subunit and a unique b-subunit [2]. Since b-subunit
confers the physiological speciﬁcity for these hormones, studies
on the regulation of gonadotropins have mainly focused on their
b-subunits.
The molecular mechanisms of the transcriptional regulation of
gonadotropins have been studied previously. However, unlikechemical Societies. Published by E
Biological Sciences, National
117543, Singapore. Fax: +65Lhb gene, whose regulatory mechanism has been elucidated and
seems to be relatively conserved among the mammalian species
(reviewed by [3]), regulations of Fshb gene are still under active
investigation and it turns out to be species-speciﬁc due to genetic
variations in the proximal promoter among several mammalian
species [4]. Previous studies on GnRH-induced regulation of Fshb
gene have successfully identiﬁed factors involved in the regulation
of basal transcriptional machinery, which include cis-elements and
transcription factors (reviewed by [4,5]). Moreover, several
GnRH-induced signaling pathways are being revealed, of which
the mitogen-activated protein kinase (MAPK) signaling pathways
are extensively studied.
To further detect the proteins involved in GnRH-induced
regulation of mFshb gene and its signal transduction pathways,
we utilized the iTRAQ quantitative proteomics approach to identify
differentially expressed proteins in the nucleus of GnRH-treated
LbT2 cells. These proteins may be important for hormone-
mediated gene regulation. Compared to the former comparative
microarray studies [6,7], this proteomics analysis may provide
protein information not only limiting to the change in abundance
but also the cellular localization, which would greatly increase
the opportunity to identify transcription factors that frequently
exert their functions through nucleo-cytoplasmic translocation.
Our study identiﬁed that a-actinin4 (ACTN4) is one of the
up-regulated proteins in the nucleus of LbT2 cells induced bylsevier B.V. All rights reserved.
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positive regulator of Fshb gene transcription, likely through its C-
terminal calmodulin (CaM)-like domain.
2. Materials and methods
2.1. Cell culture, transfection and reagents
LbT2 cells (generously provided by Dr. P. Mellon, University of
California, San Diego, USA) were cultured in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) supplemented with 10% certiﬁed fetal
calf serum, 10 mM HEPES (pH 7.4), 100 U/ml penicillin and
100 lg/ml streptomycin, which were purchased from Invitrogen
(Carlsbad, CA, USA), and were incubated at 37 C under 5% CO2.
Transfection was carried out at 70–80% conﬂuence using Lipofect-
amine 2000 (Invitrogen), and the cells were further incubated for
48–72 h before analysis.
Four-plex iTRAQ reagent kit was from AB SCIEX (MA, USA).
Polyclonal antisera against ACTN4 was purchased from immuno-
Globe (GmbH, Germany). Nucleophosmin (NPM) antibody was
purchased from Abcam (Cambridge, UK). Actin antibody was pur-
chased from BD Biosciences (CA, USA). FLAG antibody, GnRH and
phosphatase inhibitors, poly-L-lysine, paraformaldehyde, and sapo-
nin were purchased from Sigma–Aldrich (MI, USA). Glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH) antibody was
purchased from Santa Cruz (CA, USA) and the cocktail proteinase
inhibitor was obtained from Roche Diagnostics (GmbH, Germany).
All other chemicals are of analytical grade.
2.2. Protein extraction, iTRAQ identiﬁcation and western blotting
After treatment with 100 nM GnRH or mock, LbT2 cells were
rinsed with PBS, and cell pellets were collected by trypsin digestion
followed by centrifugation at 2000 rpm for 5 min. For the extrac-
tion of total proteins, the cell pellet was lysed in ice-cold RIPA buf-
fer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% Triton
X-100) followed by centrifugation at 13,000 rpm for 20 min at 4 C,
and the supernatant was used for the analysis. NE-PER kit (Pierce,
IL, USA) was used to prepare nuclear and cytoplasmic fractions. The
total protein concentration was measured by Bradford protein
assay (Bio-Rad, CA, USA), and the protein concentrations of the
nuclear and cytoplasmic fractions were determined by RC-DC
protein assay (Bio-Rad). iTRAQ identiﬁcation was carried out as
previously described [8]. The nuclear fractions of the mock-treated
and GnRH-treated LbT2 cells were labeled with 4-plex iTRAQ
reagent kit. Two biological replicates were examined for each
mock-treated and GnRH-treated samples. Western blot analysis
was performed as described by Luo et al. [9], using polyclonal
antisera against ACTN4, NPM, actin and FLAG.
2.3. Confocal microscopy of ACTN4 nuclear translocation and
quantitation
LbT2 cells were seeded on poly-L-lysine coated sterilized cover-
slips in 6-well plates and starved in serum-free medium for 16 h
before GnRH treatment. After treated for the indicated times, cells
were washed twice with ice-cold Dulbecco’s PBS (DPBS; PBS with
Ca2+ and Mg2+), and then ﬁxed in 3% paraformaldehyde at room
temperature for 15 min followed by permeabilization with PBS
containing 0.5% saponin at room temperature for 15 min. After per-
meabilization, the ﬁxed cells were blocked in DPBS containing 10%
horse serum plus 1% bovine serum albumin at room temperature
for 1 h. Incubation with primary antibodies was done for 1 h at
room temperature or overnight at 4 C. The cells were washed 3
times in DPBS containing 0.1% saponin, and incubated with the sec-
ondary antibodies for 1 h at room temperature, followed by 6 timeswashing in DPBS containing 0.1% saponin. The stained cells were
then mounted with 40,6-diamidino-2-phenylindole (DAPI) contain-
ing mounting solution (Santa Cruz), and examined using LSM510
confocal ﬂuorescence microscope (Carl Zeiss, Germany) with 63
Plan-Apo objective lens N.A. = 1.4.
For ﬂuorescence quantitation assays, the unit ﬂuorescence in
the nucleus (In) and the whole cell (Iw) were calculated as inten-
sity/area. The results were shown as the fold change over mock-
treated controls. A minimum of 50 cells (i.e., ±10 microscopic
ﬁelds) in total were counted. Statistical analyses were performed
by two-sample homoscedastic t-test.
2.4. Generation of ACTN4 constructs for overexpression and knock-
down assays
To generate the ACTN4 overexpression construct ACTN4 OE, the
full-length ACTN4 was PCR-ampliﬁed from LbT2 cDNA using
primers designed to include HindIII and XhoI restriction sites
(50-CCCAAGCTTATGGTGGACTACCACGCAGC-30 and 50-CCGCTCGA
GTCACAGGTCGCTCTCCCCAT-30). The digested product was sub-
cloned into pXJ40-FLAG vector. For CaM-deleted ACTN4 mutant,
ACTN4 gene from 1–2499 bp was PCR-ampliﬁed using the same
forward primer for the full-length ACTN4 and the reverse primer,
50-CCGCTCGAGTCAAATGAAGGCTTGGAAGGTC-30, digested and in-
serted into pXJ40-FLAG vector between HindIII and XhoI restriction
sites.
For ACTN4 knock-down experiment, two constructs siACTN4976
and siACTN42032 containing ACTN4 short hairpin RNA (shRNA)were
generated using pSUPER vector (Oligoengine, Seattle, USA). They are
designed to target two speciﬁc regions of the mouse ACTN4 mRNA.
The 19-targeted-oligonucleotides used in siACTN4976 is 50-GCACCT
GATGGAAGACTAT-30 and in siACTN42032 is 50-GCAATCCAATGAGCA
CCTT-30. The shRNA targeting green ﬂuorescence protein (shGFP)
was used as a control, as described by Luo et al. [9].
2.5. RT-PCR and real-time PCR
RNA isolation from LbT2 cells was performed using TRIzol
(Invitrogen) according to the manufacturer’s protocol, and the total
RNA (2 lg) was reverse-transcribed using SuperScript III ﬁrst-
strand synthesis system (Invitrogen). Of the 20 ll cDNA obtained,
1–2 ll was used for a semi-quantitative PCR with speciﬁc primers
as listed in Supplementary Table 1. Real-time PCR was performed
using Power SYBR PCR master mix (Applied Biosystems, CA, USA)
with an ABI 7000 sequence detector. Primers for real-time PCR
are shown in Supplementary Table 1. The samples were ﬁrst
warmed to 50 C for 2 min, and then heated to 95 C for 10 min,
followed by 40 cycles of 95 C for 15 s and 60 C for 1 min. Relative
changes in mRNA levels were calculated using DDCt method. Each
value is representative of three replicates.
2.6. Luciferase assays
The luciferase reporter construct was generated by fusing the
384/+1 bp of the mFshb-promoter to ﬁreﬂy luciferase gene
pGL4.10 (Promega, WI, USA). Fireﬂy luciferase values were normal-
ized to those of Renilla luciferase, which was cotransfected as an
internal control.
Cells were seeded in 24-well plates. After overnight plating,
500 ng/well of over-expression/shRNA constructs, 500 ng/well of
the luciferase reporter constructs and 25 ng/well of simian virus
40 (SV40) were transient–transfected for 48–72 h. After harvest,
the cell lysates were split into 96-well plate. Luciferase activity
was measured by using the Dual-Glo system (Promega), and a Ver-
ita Microplate luminometer (Turner Biosystem, CA, USA). Lucifer-
ase activity was normalized to the level of Renilla luciferase. The
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were the values generated from transfection of the luciferase re-
porter plasmids with empty vector/shGFP. Statistical analyses
were carried out by two-sample homoscedastic t-test.
3. Results and discussion
3.1. GnRH induces nuclear translocation of ACTN4
To identify novel proteins, especially the transcription factors
and cis-elements involved in GnRH regulation of gonadotropins,
we applied iTRAQ technique to compare the nuclear proteome of
GnRH-treated LbT2 cells with mock-treated control cells. ACTN4
was one of the identiﬁed proteins showing signiﬁcant abundance
change (unpublished data). The iTRAQ ratios of GnRH-treated to
mock-treated samples were 1.52 and 1.34 in two biological repli-
cates, respectively (Supplementary Table 2), indicating signiﬁcant
up-regulation of ACTN4 in LbT2 nuclear fraction by GnRH induc-
tion. To conﬁrm the up-regulation of ACTN4 in the nucleus of
GnRH-treated LbT2 cells, we examined the protein levels of ACTN4
in nucleus and cytoplasm by western blot analysis (Fig. 1A). The re-
sult demonstrates that GnRH stimulation increased the protein le-
vel of nuclear ACTN4 in both biological replicates (1.69 ± 0.21-fold
and 1.82 ± 0.07-fold, respectively), which was consistent with our
iTRAQ result.
Immunoﬂuorescence confocal microscope study was performed
to detect the subcellular distribution of endogenous ACTN4 in LbT2GnRH +- 
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Fig. 1. GnRH induced nuclear translocation of ACTN4. (A) LbT2 cells from each of the two
cytoplasmic (C) fractions were separated as indicated in Section 2. The expression level o
loading controls for nuclear and cytoplasm fractions, respectively. Representative blot w
experiments (NPM was set as the control for normalization of nuclear protein) and
(B) Redistribution of ACTN4 after GnRH treatment is indicated by the white arrows. The zo
and GnRH-treated groups were shown at the right side of the panels. LbT2 cells were
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expressed as fold change normalized to those of mock-treated controls. Values are meacells after GnRH induction. In the mock-treated cells, ACTN4 was
predominantly accumulated as a circle surrounding the inner layer
of plasma membrane. This is consistent with its role as a cytoskel-
eton protein. After GnRH treatment signiﬁcant amount of ACTN4
was redistributed to nucleus as indicated in Fig. 1B. Quantitation
data showed that nuclear ACTN4 level increased by 1.93 ± 0.25-
fold, conﬁrming nuclear translocation of ACTN4 induced by GnRH
(Fig. 1C).
ACTN4 is originally recognized as an actin-binding protein and
predominantly localized at stress ﬁbers, microﬁlament bundles,
and sites of cell contact or adhesion, engaged in organization of ac-
tin cytoskeleton and regulation of cell motility [10]. The transloca-
tion of ACTN4 from adhesion site to nucleus through actin ﬁbers
upon hormonal stimulation is an efﬁcient signaling pathway. Be-
sides, the translocation of ACTN4 may result in the actin reorgani-
zation and cause the change of the cell morphology and activate
the gene transcription. It was only until recently that the nuclear
functions of ACTN4, as a transcription factor, started to be unveiled
[11–15].
3.2. Effects of ACTN4 on the transcription of mouse gonadotropin b-
subunit genes and GnRHR gene
As we found that ACTN4 nuclear translocation is increased upon
GnRH treatment, we speculated that ACTN4 may also play a role in
regulating transcription of gonadotropins. To test this hypothesis,
the effects of overexpression and knock-down of ACTN4 wereACTN4 DAPI ACTN4+DAPI 
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tive up-regulation (7-fold) of ACTN4 by ACTN4 OE and down-reg-
ulation (4-fold) by siACTN42032. Since the knock-down efﬁciency of
siACTN4976 was not as signiﬁcant as that of siACTN42032, we only
used siACTN42032 for the following experiments. We examined
the effect of ACTN4 on the transcription of three of the tertiary
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tistically signiﬁcant, showed opposite trend to the effect by ACTN4
OE. These ﬁndings indicate that ACTN4 positively regulates the
transcription of mFshb gene.
3.3. ACTN4 regulates mFshb promoter
Since the amount of ACTN4 in nucleus increases after GnRH
treatment, we speculated that ACTN4 may exert its regulatory
roles on the mFshb promoter. Hence, we performed luciferase pro-
moter assays to assess the effect of ACTN4 on mFshb promoter
activity. As shown in Fig. 3, transient transfection of ACTN4 OE dra-
matically increased mFshb promoter activity by 1.86 ± 0.06-fold
(P < 0.001), while siACTN42032 repressed this promoter activity to
0.59 ± 0.04-fold (P < 0.001). Collectively, our data suggest that
ACTN4 is a positive regulator of mFshb gene transcription, and
likely has functional impact on mFshb promoter.
3.4. ACTN4-induced transcriptional activation of mFshb requires the
CaM-like domain
After verifying the effect of ACTN4 on the transcription ofmFshb
gene, we further investigated which domain of ACTN4 plays a role
in the transcriptional regulation. ACTN4 contains an N-terminal
actin-binding domain, a central four spectrin-repeat domain, two
EF hand Ca2+-binding domains and a C-terminal CaM-like domain.
Previous studies have found that the CaM-like domain of ACTN4
can antagonize histone deacetylase 7 (HDAC7) and consequently
potentiate myocyte enhancer factor-2 (MEF2) transcription activity
[12]. Since MEF2 family member MEF2A and MEF2D are transcrip-
tion factors bound tomFshb promoter in aT3–1 cells [17], we antic-
ipated that ACTN4 may also regulate transcription of mFshb gene
through its CaM-like domain. To test this hypothesis, the full-length
ACTN4 and its truncated mutant DCaM-ACTN4, without the CaM-
like domain, were transiently transfected into LbT2 cells. The pro-
tein expression of each construct was analyzed by western blot
(Fig. 4A). The effects of these proteins on the mRNA level of mFshb
gene were assessed by real-time PCR. The result demonstrates that
ACTN4 OE promotes mRNA level of mFshb gene to nearly 1.5-fold;
however DCaM-ACTN4 has no detectable effect (Fig. 4B).
Furthermore, luciferase assay was performed to evaluate the
effect of DCaM-ACTN4 on the mFshb promoter activity (Fig. 4C).0
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Fig. 3. Effects of ACTN4 on mFshb promoter. mFshb promoter-ﬁreﬂy luciferase
constructs were transiently transfected into LbT2 cells together with ACTN4 OE/
empty vector or siACTN4/shGFP. Fireﬂy luciferase values were normalized to those
of Renilla luciferase, and were shown as fold changes over levels in vector-
transfected LbT2 cells. Values are mean ± SEM of two independent experiments,
each performed in four replicates. ⁄⁄⁄P < 0.001.The result shows similar trends as that of real-time PCR. Compared
to the control, ACTN4 signiﬁcantly increased mFshb promoter
activity for 2-fold, while this function was almost abolished after
deleting the CaM-like domain. Our ﬁndings suggest that the C-ter-
minal CaM-like domain of ACTN4 might be involved in the regula-
tion of mFshb gene expression.0
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Fig. 4. ACTN4 induced transcription activation of mFshb requires its CaM-like
domain. (A) pXJ40-FLAG, ACTN4-FLAG and DCaM ACTN4-FLAG were transiently
transfected into LbT2 cells. The expression of full length and truncated ACTN4 was
detected by western blot with actin as loading control. (B) Real-time PCR of
regulation of ACTN4 on the Fshb gene. Total RNAs were extracted from LbT2 cells
transfected with above plasmids. Quantitative real-time PCR was performed as
described in Fig. 2 (D). (C) Luciferase assay of ACTN4 on mFshb promoter. mFshb
promoter-luciferase constructs were co-transfected with either ACTN4-FLAG,
DCaM ACTN4-FLAG or pXJ40-FLAG. Fireﬂy luciferase values were analyzed as
described in Fig. 3.
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ated transcriptional activation. Firstly, ACTN4 may promote the
transcription of mFshb through antagonizing HDACs from its pro-
moter. It has been reported that ACTN4, through its CaM-like do-
main, can compete with MEF2 for binding to HDAC7 thus
potentiate MEF2 transcription activity [12]. MEF2 is a known tran-
scription factor bound to Fshb promoter in aT3–1 cells [17]. It has
also been reported that GnRH facilitates the expression of mFshb
gene in aT3–1 cells through activating Ca2+/CaMKI (Ca2+/calmodu-
lin-dependent protein kinase I) and phosphorylating the HDACs
[17]. The phosphorylated HDACs dissociate from mFshb promoter,
thus the HDAC-mediated repression ofmFshb gene is released. This
ﬁnding indicated that GnRH stimulation may trigger the Ca2+ sig-
naling pathway as well. Thus, it is possible that ACTN4 involves
in regulating the transcription of mFshb gene through GnRH-in-
duced activation of Ca2+ signaling pathway, causing HDAC phos-
phorylation and relief of gene repression.
Secondly, it is also possible that ACTN4 may stabilize chromatin
remodeling complexes to activatemFshb transcription. In the study
of human cytochrome P450, family 1, subfamily A, polypeptide 1
(CYP1A1), association of ACTN4/nuclear factor Y (NF-Y) has been
identiﬁed and the role of ACTN4 has been proposed in assisting
NF-Y to recruit chromatin remodeling complexes or directing
ACTN4/NF-Y associated gene into active transcription [11]. Given
that murine Fshb promoter also contains a half AP-1/NF-Y binding
site [18], and this site is required for the maximal induction of
GnRH in LbT2 cells [19], we speculate that ACTN4 may help to sta-
bilize chromatin remodeling complexes or orchestrate target genes
to facilitate the transcription activation induced by GnRH.
Thirdly, ACTN4 may link Ca2+ signaling and MAPK signaling
during the GnRH-mediated signal transduction pathways. It is
known that the MAPK pathway is important for GnRH signaling
in the regulation of synthesis of gonadotropins. Previous study
on calmodulin in aT3-1 cells suggested that it may act as a Ca2+
sensor, which links Ca2+ ﬂux with extracellular regulated kinase
(ERK) activation within the GnRH signaling [20]. It is evident that
ERK is a crucial intermediate to transduce the signal from GnRH
to Fshb. Inhibition of ERK decreased GnRH-induced mFshb pro-
moter activity in LbT2 cells [19] and attenuated GnRH-stimulated
mRNA level as well as FSH release in male rat primary pituitary
cultures [21]. In this study, we demonstrate that ACTN4 may play
an essential role on the mFshb promoter through its CaM-like do-
main. Therefore, it is plausible that ACTN4 also provides a link be-
tween Ca2+ signaling and MAPK signaling during the GnRH-
mediated signal transduction pathways [22]. Further experiments
will be required to verify this complex signaling process.
4. Conclusions
To summarize, we have demonstrated that the nuclear translo-
cation of ACTN4 is involved in the regulation of mFshb gene tran-
scription by GnRH, and its CaM-like domain is required for this
function. Our ﬁndings suggest that GnRH-induced ACTN4 nuclear
translocation may facilitate the transcriptional activation of mFshb
gene, possibly through mediating the crosstalk of Ca2+ signaling
with the MAPK pathways.
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